These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23088113)

  • 1. [Features of formation of postvaccinal immunity in the population of one-company towns and rural settlements 1].
    Boev MV; Moev VM; Borisov SD
    Gig Sanit; 2012; (3):19-21. PubMed ID: 23088113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of environmental factors on the formation of postvaccinal immunity].
    Boev MV; Kryazhev DA; Boev VM
    Gig Sanit; 2014; (5):52-4. PubMed ID: 25831929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of environmental factors on the pediatric population in the urbanized and rural areas of the Orenburg Region].
    Setko AG; Vial'tsina NE
    Gig Sanit; 2009; (4):58-60. PubMed ID: 19802949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination and herd immunity: what more do we know?
    Rashid H; Khandaker G; Booy R
    Curr Opin Infect Dis; 2012 Jun; 25(3):243-9. PubMed ID: 22561998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [COMPLEX ASSESSMENT OF ENVIRONMENTAL FACTORS AND POSTVACCINAL IMMUNE STATE].
    Kryazhev DA; Boev MV; Tulina LM; Neplokhov AA; Boev VM
    Gig Sanit; 2016; 95(3):229-32. PubMed ID: 27266020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hopf bifurcation in epidemic models with a time delay in vaccination.
    Khan QJ; Greenhalgh D
    IMA J Math Appl Med Biol; 1999 Jun; 16(2):113-42. PubMed ID: 10399309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational exemption to vaccination for non-fatal SIS diseases: globally stable and oscillatory endemicity.
    Buonomo B; D'Onofrio A; Lacitignola D
    Math Biosci Eng; 2010 Jul; 7(3):561-78. PubMed ID: 20578786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next Generation Vaccines for Infectious Diseases.
    Sautto GA; Kirchenbaum GA; Diotti RA; Criscuolo E; Ferrara F
    J Immunol Res; 2019; 2019():5890962. PubMed ID: 31183388
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of infection by protective vaccination. Active immunization].
    Weber-Oldecop H
    ZFA (Stuttgart); 1983 Feb; 59(4):166-73. PubMed ID: 6845839
    [No Abstract]   [Full Text] [Related]  

  • 10. Determinants of apparent rural-urban differentials in measles vaccination uptake in Indonesia.
    Fernandez RC; Awofeso N; Rammohan A
    Rural Remote Health; 2011; 11(3):1702. PubMed ID: 21899375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for assessing cell-mediated immunity in infectious disease resistance and in the development of vaccines.
    Clough NE; Roth JA
    J Am Vet Med Assoc; 1995 Apr; 206(8):1208-16. PubMed ID: 7768746
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-specific effects of vaccination: vaccines have non-specific (heterologous) effects.
    Shann F
    BMJ; 2005 Apr; 330(7495):844; author reply 844. PubMed ID: 15817557
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune recognition, control of infections and vaccination strategies.
    Ciba Found Symp; 1997; 204():142-7. PubMed ID: 9107417
    [No Abstract]   [Full Text] [Related]  

  • 14. A small jab - a big effect: nonspecific immunomodulation by vaccines.
    Benn CS; Netea MG; Selin LK; Aaby P
    Trends Immunol; 2013 Sep; 34(9):431-9. PubMed ID: 23680130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of vaccination against infectious disease in children in 2003.
    Lajeunesse M
    Expert Rev Vaccines; 2003 Oct; 2(5):611-4. PubMed ID: 14711322
    [No Abstract]   [Full Text] [Related]  

  • 16. An unprotected public.
    Kahn J
    Am J Bioeth; 2008 Jun; 8(6):3-4. PubMed ID: 18726767
    [No Abstract]   [Full Text] [Related]  

  • 17. New adjuvants for human vaccines.
    Mbow ML; De Gregorio E; Valiante NM; Rappuoli R
    Curr Opin Immunol; 2010 Jun; 22(3):411-6. PubMed ID: 20466528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The concept of herd immunity applied to the evaluation of vaccination programs].
    Zieliński A
    Przegl Epidemiol; 1999; 53(3-4):245-55. PubMed ID: 10800562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives.
    Gomes MG; White LJ; Medley GF
    J Theor Biol; 2004 Jun; 228(4):539-49. PubMed ID: 15178201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What to expect of future vaccines?
    Morein B; Lövgren Bengtsson K; Villacres-Eriksson M
    Acta Vet Scand Suppl; 1996; 90():101-6. PubMed ID: 8996895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.